An interventional study of The patient will be equipped with VR headsets in Peripheral Arterial Disease, sponsored by Poitiers University Hospital. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-31.
Sponsored by Poitiers University Hospital · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 120 studies in Peripheral Arterial Disease with a site in France — 21 open to participants now, 27 under way, 4 of them phase 3. Peripheral Arterial Disease · France.
Among the 120 studies in Peripheral Arterial Disease with a site in France, this one is the 37th largest by planned enrollment of the 66 interventional ones that give a count, is one of 2 that started in 2026, is one of 43 with no phase, reaches primary completion later than 18 of the 26 other live ones, and was the 115th registered.
1,378 studies on the registry are indexed under Peripheral Arterial Disease; 276 are open to participants now.
Browse Peripheral Arterial Disease studies →21 of the 120 studies in Peripheral Arterial Disease with a site in France are open now. Recruiting first, the newest first:
Intervascular · Sites in France, United States, Belgium and 1 more country
Ages 18+
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · Sites in France
Ages 18+
Eli Lilly and Company · Sites in France, United States, Argentina and 15 more countries
Ages 18+
Atrium Medical Corporation · Sites in France, United States
Ages 18+
Biotronik AG · Sites in France, Austria, Belgium and 5 more countries
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 193 Peripheral Arterial Disease studies recruiting now, 139 (72%) set no upper age limit and 9 (5%) stop at 75 or younger; 13 take children under 18; 19 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
120 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 5 · Phase 3 13 · Phase 4 7
First in 2002; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 70 across 927 interventional studies indexed under Peripheral Arterial Disease.
Median enrollment 106 across the 66 interventional studies, 298 across the 54 observational. Of the 82 that completed or were terminated, 12 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
45 of 120 have an industry lead sponsor. The 10 most frequent:
Poitiers University Hospital is the lead sponsor of 315 studies on the registry; 63 are open to participants now.
Poitiers University Hospital has 1 study filed under Peripheral Arterial Disease — fewer than ten, so there is no comparison to draw.
4 of the studies in Peripheral Arterial Disease with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07283289Centre Hospitalier Intercommunal de Toulon La Seyne sur MerPrevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease | 2026-11 |
| NCT05055297M.A. Med Alliance S.A.SELUTION4BTK Trial | 2027-06-01 |
| NCT07322913IntervascularIntervascular Post-Market Clinical Follow-Up (PMCF) Registry | 2027-07 |
| NCT07181434Poitiers University HospitalImpact of Virtual Reality on Patient Pain During Lower Limb Revascularization Via Endovascular Surgery Under Local Anesthesia With Sedation | 2027-09-03 |
Add all 4 to your calendar (.ics) → With an account.
Among the 120 studies in Peripheral Arterial Disease with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The prevalence of peripheral arterial disease (PAD) increases with age In addition to medical treatment, endovascular procedures can be performed, depending on the stage of the disease, to prevent complications and/or sequelae (relapse, functional loss of the affected limb, amputation, death), but also to relieve pain. This is a minimally invasive procedure most often performed under local anesthesia (LA), sometimes with the administration of sedatives (morphine and analgesics) to relieve pain and reduce anxiety related to the procedure.
Non-pharmacological methods such as virtual reality (VR) are increasingly being used as an alternative to general anesthesia and excessive opioid use.
The hypothesis is that VR could reduce pain during lower limb revascularization by endovascular surgery.
The prevalence of peripheral arterial disease (PAD) increases with age. In high-income countries, it is 5% between the ages of 45 and 49, and 18% after the age of 85. In France, nearly 1 million people are affected by this disease.
In addition to medical treatment, endovascular procedures can be performed, depending on the stage of the disease, to prevent complications and/or sequelae (relapse, functional loss of the affected limb, amputation, death), but also to relieve pain. This is a minimally invasive procedure most often performed under local anesthesia (LA), sometimes with the administration of sedatives (morphine and analgesics) to relieve pain and reduce anxiety related to the procedure.
Local anesthesia causes discomfort related to the operating environment (low temperature, harsh lighting, noise, supine position, arms along the body, cold, hard, narrow table), impacting patient cooperation and making the procedure difficult, with the need to take multiple X-rays and reinject potentially nephrotoxic contrast agents. It can lead to the procedure being stopped, with serious consequences (postponement, persistent or even worsening pain, amputation, death).
Non-pharmacological methods such as virtual reality (VR) are increasingly being used as an alternative to general anesthesia and excessive opioid use.
It has proven effective in managing pain and anxiety during various medical, surgical, and endovascular procedures. Its high-quality graphics immerse the patient; hypnotic speech and relaxing elements capture the patient's attention; breathing exercises help manage stress; and relaxing music creates a soothing atmosphere. This support ensures greater mental and physical comfort by reducing pain and anxiety.
The hypothesis is that VR could reduce pain during lower limb revascularization by endovascular surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
In addition to the usual care, the patient will be equipped with VR headsets showing one of the six scenes from the HealthyMind® program in 3D, accompanied by hypnotic speech during the procedure.
Device: The patient will be equipped with VR headsets
The patient will receive standard care under local anesthesia with an analgesic injection (paracetamol) +/- morphine sedation (remifentanil), according to the treatment protocol and tailored to the patient.
The patient will be equipped with VR headsets showing one of the six scenes from the HealthyMind® program in 3D, accompanied by hypnotic speech during the procedure.
The maximum level of pain experienced by the patient during the procedure
The maximum level of pain will be assessed at the the end of the procedure using a numerical rating scale ranging from 0 (no pain) to 10 (worst pain imaginable)
Time frame: At the end of the revascularization procedure
The difference in anxiety measures assessed at baseline and just after the intervention
Anxiety will be measured at baseline and just after the intervention using a numerical rating scale ranging from 0 for "no anxiety" to 10 for "maximum imagined anxiety": a quick, easy-to-use scale that correlates strongly with Spielberger's STAI scale (Benotsch et al., 2000).
Time frame: At Baseline and just after the intervention of lower limb revascularization through endovascular surgery
Systolic Blood Pressure (SBP) in mmHg
Time frame: At Baseline before the procedure of lower limb revascularization through endovascular surgery, upon arrival in the operating room, then every 15 minutes until the end of the procedure.
Diastolic Blood Pressure (DBP) in mmHg
Time frame: At Baseline before the procedure of lower limb revascularization through endovascular surgery, upon arrival in the operating room, then every 15 minutes until the end of the procedure.
Heart Rate (HR) in cycles/min
Time frame: At Baseline before the procedure of lower limb revascularization through endovascular surgery, upon arrival in the operating room, then every 15 minutes until the end of the procedure.
Respiratory Rate (RR) in Breaths Per Minute (BPM)
Time frame: At Baseline before the procedure of lower limb revascularization through endovascular surgery, upon arrival in the operating room, then every 15 minutes until the end of the procedure.
Cumulated doses of analgesics consumed during the procedure (in mL/kg)
Cumulated doses will be standardized in mL/kg in order to obtain comparable measures accros patients
Time frame: During the revascularization procedure
The dose of X-ray radiation
Total dose of X-ray radiation absorbed by the patient (dose-area product, in mGy.cm²)
Time frame: During the procedure of revascularization of the lower limbs by endovascular surgery
The total volume of contrast medium delivered during the procedure
Time frame: During the procedure of revascularization of the lower limbs by endovascular surgery
The difference between the duration of the procedure as perceived by the patient and the actual duration of the procedure (in minutes)
Time frame: At the end of the procedure of revascularization of the lower limbs by endovascular surgery
The success rate of the procedure
Proportion of procedures performed successfully (total revascularization of the artery)
Time frame: At the end of the procedure of revascularization of the lower limbs by endovascular surgery
Proportion of patients who kept the virtual reality headsets on throughout the procedure
Outcome assessed for the experimental group only (with VR headset)
Time frame: Throughout the procedure of lower limb revascularization through endovascular surgery
Satisfaction level of the virtual reality headset
Satisfaction will be measured with a numerical rating scale ranging from 0 (not satisfied at all) to 10 (completely satisfied). Outcome assessed for the experimental group only (with VR headset)
Time frame: At the end of the procedure of lower limb revascularization through endovascular surgery
Comfort level experienced by the patient during the procedure
Comfort will be measured after the procedure using a numerical rating scale ranging from 0 (very uncomfortable) to 10 (very comfortable).
Time frame: Comfort will be assessed at the end of the revascularization procedure
Cumulated doses of morphine derivatives consumed during the procedure (in mL/kg)
Cumulated doses will be standardized in mL/kg in order to obtain comparable measures accross patients
Time frame: During the revascularization procedure
Cumulated doses of anesthetics consumed during the procedure (in mL/kg)
Cumulated doses will be standardized in mL/kg in order to obtain comparable measures accross patients
Time frame: During the revascularization procedure
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Mar 2026 (actual). Primary completion is estimated for Sep 2027, 18 months after the start.
Of 261 non-industry interventional studies with no phase under Peripheral Arterial Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 64. This study's planned 18 months is below that.
Counting every sponsor, half of 386 studies reached it within 31 months; a quarter within 17 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Poitiers University Hospital →